WHO issues guidelines on managing Covid-linked inflammatory condition in children

Our Bureau | | Updated on: Nov 23, 2021
image caption

Recommends the use of corticosteroids in hospitalised children

The World Health Organization (WHO) has issued updated guidelines on the management of multisystem inflammatory syndrome in children associated with Covid-19 (MIS-C).

“MIS-C is a rare but serious condition where children with Covid-19 develop inflammation affecting different organs of the body. Children with this condition need specialised care and may need to be admitted to intensive care. Although MIS-C is a serious condition, with the right medical care, children with this condition recover,” WHO said.

WHO’s updated guidelines recommend the use of corticosteroids in hospitalised children (aged 0-18 years) with this condition, in addition to supportive treatment and care. This recommendation comes following the availability of three observational studies, pooling data from 885 patients in total.

Overall, children remain at a low risk of developing severe or critical Covid-19 but similar to adults, certain underlying conditions make children more susceptible to severe disease. The most commonly reported of these conditions are obesity, chronic lung disease (including asthma), cardiovascular disease and immunosuppression, the WHO said.

Published on November 23, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you